NCT00150605View on ClinicalTrials.gov

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

October 31, 2005

Conditions
Bipolar Disorder
Interventions
DRUG

Extended-release carbamazepine

Sponsors
All Listed Sponsors
lead

Validus Pharmaceuticals

INDUSTRY